Merck to take legal action against unauthorised distributors of its COVID treatment in China
Merck added that Sinopharm is the only legally authorised distributor of Merck's COVID-19 anti-viral molnupiravir in China
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Merck
China grants conditional approval for Merck’s COVID treatment
Molnupiravir, developed by Merck, is approved to be used in adult patients who have mild-to-medium COVID infection and a high risk…
Meeting on introduction of HPV vaccine in immunisation programme held; SII and Merck representatives…
Representatives of the Serum Institute of India (SII) and Merck were present in the meeting held last week and deliberated on…
Shionogi says Japan government to buy one million more COVID pill doses
Shionogi previously agreed to sell a million doses of the drug, a protease inhibitor known as ensitrelvir and commercially as…
Indonesia to produce Merck’s HPV vaccines to combat cervical cancer
Honesti Basyir, Chief, Bio Farma, said in a statement that the company has signed a technology transfer deal with Merck to help…
Merck elects Robert M Davis as company Chairman
He will succeed Kenneth C Frazier, who plans to retire on 30th Novemeber, 2022
EC approves expanded indication for Merck’s Pneumococcal 15-valent Conjugate Vaccine
The approval facilitates availability of Vaxneuvance for this population in all 27 European Union (EU) member states plus Iceland,…
Merck under formal investigation in France over thyroid drug
The ruling by a judge in the French city of Marseille did not concern in any way the new formula for the Levothyrox product, but…
Merck to initiate new clinical programme with lower dose of daily oral Islatravir in combination…
Phase-II study evaluating an investigational weekly oral combination treatment regimen of Islatravir and Gilead Sciences’…